MedPath

Improving Quality by Maintaining Accurate Problems in the EHR

Not Applicable
Completed
Conditions
Coronary Artery Disease
Smoking
Hypertension
Sleep Apnea
Asthma
Atrial Fibrillation
Myocardial Infarction
Sickle Cell Disease
Tuberculosis
Chronic Obstructive Pulmonary Disease
Interventions
Other: Problem List Suggestion
Registration Number
NCT02596087
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

The overall goal of the IQ-MAPLE project is to improve the quality of care provided to patients with several heart, lung and blood conditions by facilitating more accurate and complete problem list documentation. In the first aim, the investigators will design and validate a series of problem inference algorithms, using rule-based techniques on structured data in the electronic health record (EHR) and natural language processing on unstructured data. Both of these techniques will yield candidate problems that the patient is likely to have, and the results will be integrated. In Aim 2, the investigators will design clinical decision support interventions in the EHRs of the four study sites to alert physicians when a candidate problem is detected that is missing from the patient's problem list - the clinician will then be able to accept the alert and add the problem, override the alert, or ignore it entirely. In Aim 3, the investigators will conduct a randomized trial and evaluate the effect of the problem list alert on three endpoints: alert acceptance, problem list addition rate and clinical quality.

Detailed Description

The clinical problem list is a cornerstone of the problem-oriented medical record. Problem lists are used in a variety of ways throughout the process of clinical care. In addition to its use by clinicians, the problem list is also critical for decision support and quality measurement.

Patients with gaps in their problem list face significant risks. For example, if a hypothetical patient has diabetes properly documented, his clinician would receive appropriate alerts and reminders to guide care. Additionally, the patient might be included in special care management programs and the quality of care provided to him would be measured and tracked. Without diabetes on his problem list, he might receive none of these benefits.

In this study, the investigators developed an clinical decision support intervention that will identify patients with problem lists gaps. The investigators will alert providers of these likely gaps and offer providers the opportunity to correct them.

In the first aim, the investigators will design and validate a series of problem inference algorithms, using rule-based techniques on structured data in the electronic health record (EHR) and natural language processing on unstructured data. Both of these techniques will yield candidate problems that the patient is likely to have, and the results will be integrated. In Aim 2, the investigators will design clinical decision support interventions in the EHRs of the four study sites to alert physicians when a candidate problem is detected that is missing from the patient's problem list - the clinician will then be able to accept the alert and add the problem, override the alert, or ignore it entirely. In Aim 3, the investigators will conduct a randomized trial and evaluate the effect of the problem list alert on three endpoints: alert acceptance, problem list addition rate and clinical quality.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2386
Inclusion Criteria
  • All providers over the age of 18 that use the electronic health record at the specific site that the intervention is being observed.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention ArmProblem List SuggestionSites will configure their EHR systems so that alerts for these conditions will be triggered for providers in the intervention arm if the patient does not have the condition on her/his problem list. Each alert will be actionable and allow the provider to add the problem to her or his patient's problem list with a single click. The provider will also be able to override the rule of the patient does not have the condition (in which case the alert will not be displayed again unless new information that would trigger the alert is added to the patient's record), or defer the alert until later.
Primary Outcome Measures
NameTimeMethod
Measuring the rate of acceptance of alerts calculated by number of acceptances for each alert divided by the total number of unique presentations of the alertThrough study completion, or up to 1 year

Acceptance of the alerts:

This first endpoint is descriptive: the acceptance rate for the alerts presented to providers. This will be calculated by taking the total number of acceptances for each alert and dividing it by the total number or unique presentations of the alert. We will conduct a stratified analysis to look at differences in acceptance rates by institution, specialty, disease and provider demographic characteristics, and will report the results in tabular form.

Determining the effect of problem list completion by comparing the number of study-related problems added to problem lists in the electronic health recordThrough study completion, or up to 1 year

Effect on the rate of problem list completion:

In this endpoint, we will compare the number of study-related problems added to patient problems lists in the electronic health record in the intervention and control groups.

Determining the quality of care impact of adding suggested problems to the problem list based on 4 outcome measures from NCQA's HEDIS 2013 measure setThrough study completion, or up to 1 year

Effect on quality of care:

Because a key goal of our study is improving clinical outcomes, we have selected four outcome measures to evaluate from NCQA's Healthcare Effectiveness Data and Information Set (HEDIS) 2013 measure set: LDL control in patients with a history of myocardial infarction, LDL control in patients with coronary artery disease, blood pressure control in patients with coronary artery disease and blood pressure control in patients with hypertension. The details for the numerator and denominator for each measure are given in the HEDIS manuals, and our study team will employ NCQA's procedures for calculation of each measure, with modifications as needed given the clinical nature of our dataset.

Secondary Outcome Measures
NameTimeMethod
Evaluating process measures using key process measures for each study condition from CMS, NHLBI, and NQMCThrough study completion, or up to 1 year

Improvements for process measures To complete the clinical endpoints in the third outcome, we will also evaluate process measures, specifically frequency of LDL testing, prescription of antihyperlipidemic agents, prescription of aspirin or other antiplatelet agents and prescription of antihypertensive agents. We will analyze the results using logistic regression with fixed effects for intervention group (versus control) and site and estimation of the regression parameters with generalized estimating equations (GEE), accounting for clustering between the patients in the same physician as well as patients with different physicians in the same matched pair. We will build separate regression models for each quality measure, and also conduct a pooled analysis with additional effects for quality measure and availability of CDS for the associated measure at the site, in order to estimate the extent to which IQ-MAPLE's effect on quality is mediated by CDS.

Trial Locations

Locations (4)

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Oregon Health and Science University

🇺🇸

Portland, Oregon, United States

Holy Spirit Hospital

🇺🇸

Camp Hill, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath